Cohen C, Joly F, et al. Randall-type monoclonal immunoglobulin deposition disease: new insights into the pathogenesis, diagnosis and management. Diagnostics (Basel). 2021;11(3):420.
Article CAS PubMed Google Scholar
Randall RE, WilliamsonJr WC, et al. Manifestations of systemic light chain deposition. Am J Med. 1976;60(2):293–9.
Article CAS PubMed Google Scholar
Ganeval D, Noël LH, et al. Light-chain deposition disease: its relation with AL-type amyloidosis. Kidney Int. 1984;26(1):1–9.
Article CAS PubMed Google Scholar
Joly F, Cohen C, et al. Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study. Blood. 2019;133(6):576–87.
Article CAS PubMed Google Scholar
Royer B, Arnulf B, et al. High dose chemotherapy in light chain or light and heavy chain deposition disease. Kidney Int. 2004;65(2):642–8.
Article CAS PubMed Google Scholar
Fukagawa M, Yokoyama K, et al. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial. 2013;17(3):247–88.
Molina-Andújar A, Robles P, et al. The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease. BMC Nephrol. 2020;21(1):111.
Article PubMed PubMed Central Google Scholar
Finney GR. Normal pressure hydrocephalus. Int Rev Neurobiol. 2009;84:263–81.
Yamamoto T. History of stress-related health changes: a cue to pursue a diagnosis of latent primary adrenal insufficiency. Intern Med. 2014;53(3):183–8.
Younes N, Bourdeau I, et al. Latent adrenal insufficiency: from concept to diagnosis. Front Endocrinol (Lausanne). 2021;27(12):720769.
Bornstein SR, Allolio B, et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364–89.
Article CAS PubMed Google Scholar
Dekkers OM, Timmermans JM, et al. Comparison of the cortisol responses to testing with two doses of ACTH in patients with suspected adrenal insufficiency. Eur J Endocrinol. 2011;164(1):83–7.
Article CAS PubMed Google Scholar
Giordano R, Balbo M, et al. Corticotrope hypersecretion coupled with cortisol hypo-responsiveness to stimuli is present in patients with autoimmune endocrine diseases: evidence for subclinical primary hypoadrenalism? Eur J Endocrinol. 2006;155(3):421–8.
Article CAS PubMed Google Scholar
Baruah MP. Sub-clinical addison’s disease. Ind J Endocrinol Metab. 2012;16(Suppl 2):S176–7.
Oprea A, Bonnet NCG, et al. Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency. Ther Adv Endocrinol Metab. 2019;2(10):2042018818821294.
Aoki N. Lumboperitoneal shunt: clinical applications, complications, and comparison with ventriculoperitoneal shunt. Neurosurgery. 1990;26(6):998–1003.
Article CAS PubMed Google Scholar
Elshirbiny MF, Badr H, et al. Migration complications of lumboperitoneal shunts. Egypt J Neurosurg. 2022;37:36.
Ho YJ, Chiang WC, et al. Effectiveness and safety of ventriculoperitoneal shunt versus lumboperitoneal shunt for communicating hydrocephalus: a systematic review and meta-analysis with trial sequential analysis. CNS Neurosci Ther. 2023;29(3):804–15.
Article PubMed PubMed Central Google Scholar
Kornaropoulos M, Makris M, et al. Bowel perforation by lumbar-peritoneal (LP) shunt: a rare complication of neurosurgery. Int J Surg Case Rep. 2018;44:217–9.
Comments (0)